Clinical trials
Completed Pathologic Complete Response trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| BioFire Diagnostics, LLC | 1 |
| Celgene | 1 |
| Doc Lab Inc | 1 |
| GlaxoSmithKline | 1 |
| NICHD Neonatal Research Network | 1 |
| Novartis | 1 |
| Sellas Life Sciences Group | 1 |
| State University of New York - Upstate Medical University | 1 |
| Valentin Fuster | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Complete Response | 11 |
| Leukemia, Myeloid, Acute | 4 |
| Leukemia | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| COVID-19 | 1 |
| Candidiasis | 1 |
| Carcinoma, Renal Cell | 1 |
| Communicable Diseases | 1 |
| Disease | 1 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.